Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $93
LeMaitre Vascular, Inc. -1.51%
LeMaitre Vascular, Inc. LMAT | 92.62 | -1.51% |
Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:
LMAT) with a Outperform and raises the price target from $92 to $93.
